The effects of fall-risk-increasing drugs on postural control: A literature review

Drugs and Aging

Volumn 30, Issue 11, 2013, Pages 901-920

  De Groot, Maartje H ^a   Van Campen, Jos P C M ^a   Moek, Marije A ^b   Tulner, Linda R ^a   Beijnen, Jos H ^a,c   Lamoth, Claudine J C ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPIDEM; AMISULPRIDE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BEFLOXATONE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CARBAMAZEPINE; CARDIAC AGENT; CHLORPROMAZINE; DESIPRAMINE; DIAZEPAM; FEMOXETINE; FLURAZEPAM; HALOPERIDOL; MINAPRINE; NEUROLEPTIC AGENT; NITRAZEPAM; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; REMOXIPRIDE; RISPERIDONE; SULPIRIDE; TIAPRIDE; UNINDEXED DRUG; ZALEPLON; ZIMELDINE;

ALCOHOL WITHDRAWAL; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ASCITES; ATAXIA; BLURRED VISION; BODY EQUILIBRIUM; BODY MOVEMENT; BODY POSTURE; BONE DENSITY; COGNITION; DAYTIME SOMNOLENCE; DEMENTIA; DEPRESSION; DIZZINESS; DRUG EFFECT; DRUG HALF LIFE; EPILEPSY; FALL RISK; FALL RISK ASSESSMENT; FALLING; GAIT; HANGOVER; HEAD INJURY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIP FRACTURE; HUMAN; HYPERTENSION; HYPOKALEMIA; INSOMNIA; LIVER CIRRHOSIS; META ANALYSIS (TOPIC); MUSCLE RELAXATION; MUSCLE WEAKNESS; NEPHROTIC SYNDROME; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PANIC; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; SEIZURE; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; UNSTEADY GAIT; VITAMIN BLOOD LEVEL;

ACCIDENTAL FALLS; CARDIOVASCULAR AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; POSTURE; PSYCHOTROPIC DRUGS; RISK;

EID: 84886509374     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0113-9     Document Type: Review

References (170)

1. Ziere G, Dieleman JP, Hofman A, Pols HAP, Van der Cammen TJM, Stricker BHC. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61(2):218-23.
2. Beers MH, Baran RW, Frenia K. Drugs and the elderly, part 1: the problems facing managed care. Am J Manag Care. 2000;6(12):1313-20.
3. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51(5):671-7.
4. Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. Use of psychotropics among home-dwelling nondemented and demented elderly. Int J Geriatr Psychiatry. 2003;18(9):1135-41.
5. Zuidema SU, De Jonghe JFM, Verhey FR, Koopmans TCM. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians' prescription behavior. Int Psychogeriatr. 2011;23(10):1632-9.
6. Bloch F, Thibaud M, Dugué B, Brèque C, Rigaud A-S, Kemoun G. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health. 2011;23(2):329-46.
7. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952-60.
8. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol Ser A Biol Sci Med Sci. 2007;62A(10):1172-81.
9. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30-9.
10. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47(1):40-50.
11. Van der Velde N, Stricker BHC, Pols HAP, Van der Cammen TJM. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol. 2007;63(2):232-7.
12. Campbell AJ, Robertson MC, Gardner MM, Norton N, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls, a RCT. J Am Geriatr Soc. 1999;47(7):850-3.
13. Salonoja M, Salminen M, Vahlberg T, Aarnio P. Withdrawal of psychotropic drugs decreases the risk of falls requiring treatment. Arch Gerontol Geriatr. 2012;54(1):160-7.
14. Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging. 2012;29(1):15-30.
15. Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall? JAMA. 2007;297(1):77-86.
16. Lord SR, Anstey KJ, Williams P, Ward JA. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol. 1995;39(3):227-34.
17. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-84.
18. Pollock AS, Durward BR, Rowe PJ, Paul JP. What is balance? Clin Rehabil. 2000;14(4):402-6.
19. Lamoth CJC, Van Heuvelen MJG. Sports activities are reflected in the local stability and regularity of body sway: older ice-skaters have better postural control than inactive elderly. Gait Posture. 2012;35(3):489-93.
20. Vuillerme N, Nafati G. How attentional focus on body sway affects postural control during quiet standing. Psychol Res. 2007;71(2):192-200.
21. Lamoth CJC, Van Lummel RC, Beek PJ. Athletic skill level is reflected in body sway: a test case for accelometry in combination with stochastic dynamics. Gait Posture. 2009;29(4):546-51.
22. Schmit JM, Regis DI, Riley MA. Dynamic patterns of postural sway in ballet dancers and track athletes. Exp Brain Res. 2005;163(3):370-8.
23. Sturnieks DL, St George R, Lord SR. Balance disorders in the elderly. Clin Neurophysiol. 2008;36(6):467-78.
24. Howe TE, Rochester L, Neil F, Skelton DA, Ballinger C. Exercise for improving balance in older people. Cochrane Database Syst Rev. 2011;11:CD004963.
25. Schmit JM, Riley MA, Dalvi A, Sahay A, Shear PK, Shockley KD, et al. Deterministic center of pressure patterns characterize postural instability in Parkinson's disease. Exp Brain Res. 2006;168(3):357-67.
26. Houdijk H, Nooijen C, Rijntjes D, Tolsma M, Lamoth CJC, Ter Hoeve N. Energy expenditure of stroke patients during postural control tasks. Gait Posture. 2010;32(3):321-6.
27. Menz HB, Lord SR, Fitzpatrick RC. Age-related differences in walking stability. Age Ageing. 2003;32(2):137-42.
28. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-8.
29. Berg KO, Maki BE, Williams JI, Holliday PJ, Wood-Dauphinee SL. Clinical and laboratory measures of postural balance in an elderly population. Arch Phys Med Rehabil. 1992;73(11):1073-80.
30. Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34(2):119-26.
31. Gil AWO, Oliveira MR, Coelho VA, Carvalho CE, Teixeira DC, Da Silva RA. Relationship between force platform and two functional tests for measuring balance in the elderly. Rev Bras Fisioter. 2011;15(6):429-35.
32. Lamoth CJC, Van Deudekom FJ, Van Campen JPCM, Appels BA, De Vries OJ, Pijnappels M. Gait stability and variability measures show effects of impaired cognition and dual tasking in frail people. J NeuroEng Rehabil. 2011;8(1):2.
33. Lamoth CJC, Ainsworth E, Polomski W, Houdijk H. Variability and stability analysis of walking of transfemoral amputees. Med Eng Phys. 2010;32(9):1009-14.
34. IJmker T, Lamoth CJC. Gait and cognition: the relationship between gait stability and variability with executive function in persons with and without dementia. Gait Posture. 2012;35(1):126-30.
35. Kinirons MT, Jackson SH, Kalra L, Trevit RT, Swift CG. Computerised psychomotor performance testing: a comparative study of the single dose pharmacodynamics of minaprine and amitriptyline in young and elderly subjects. Br J Clin Pharmacol. 1993;36(4):376-9.
36. Legangneux E, McEwen J, Wesnes KA, Bergougnan L, Miget N, Canal M, et al. The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers. J Psychopharmacol. 2000;14(2):164-71.
37. Fagan D, Scott DB, Mitchell M, Tiplady B. Effects of remoxipride on measures of psychological performance in healthy volunteers. Psychopharmacology. 1991;105(2):225-9.
38. Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA. Lamotrigine (BW430C), a potential anticonvulsant: effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol. 1985;20(6):619-29.
39. Swift CG, Ewen JM, Clarke P, Stevenson IH. Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. Br J Clin Pharmacol. 1985;20(2):111-8.
40. Swift CG, Swift MR, Ankier SI, Pidgen A, Robinson J. Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. Br J Clin Pharmacol. 1985;20(2):119-28.
41. Briggs RS, Castleden CM, Kraft CA. Improved hypnotic treatment using chlormethiazole and temazepam. Br Med J. 1980;280(6214):601-4.
42. Swift CG, Haythorne JM, Clarke P, Stevenson IH. Cardiovascular, sedative and anticholinergic effects of amitriptyline and zimelidine in young and elderly volunteers. Acta Psychiatr Scand Suppl. 1981;290:425-32.
43. Van Steveninck AL, Gieschke R, Schoemaker RC, Roncari G, Tuk B, Pieters MSM, et al. Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol. Br J Clin Pharmacol. 1996;41(6):565-73.
44. Gerrard L, Wheeldon NM, McDevitt DG. Effect of combined atenolol and nifedipine administration on psychomotor performance in normal subjects. Eur J Clin Pharmacol. 1995;48(3-4):229-33.
45. Gerrard L, Wheeldon NM, McDevitt DG. Central effects of combined bendrofluazide and atenolol administration: a single dose study in normal subjects. Eur J Clin Pharmacol. 1993;45(6):539-43.
46. De Haas SL, Franson KL, Schmitt JAJ, Cohen AF, Fau JB, Dubruc C, et al. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers. J Psychopharmacol. 2009;23(6):625-32.
47. De Haas SL, De Visser SJ, Van der Post JP, Schoemaker RC, Van Dyck K, Murphy MG, et al. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers. J Psychopharmacol. 2008;22(1):24-32.
48. De Haas SL, De Visser SJ, Van der Post JP, De Smet M, Schoemaker RC, Rijnbeek B, et al. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. J Psychopharmacol. 2007;21(4):374-83.
49. Swift CG, Haythorne JM, Clarke P, Stevenson IH. The effect of ageing on measured responses to single doses of oral temazepam. Br J Clin Pharmacol. 1981;11:413P-4P.
50. Van der Post JP, Schram MT, Schoemaker RC, Pieters MSM, Fuseau E, Pereira A, et al. CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia. 2002;22(4):271-81.
51. De Haas SL, Schoemaker RC, Van Gerven JMA, Hoever P, Cohen AF, Dingemanse J. Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects. J Psychopharmacol. 2010;24(11):1619-29.
52. Hamilton MJ, Cohen AF, Yuen AW, Harkin N, Land G, Weatherley BC, et al. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia. 1993;34(1):166-73.
53. Hockings N, Pall A, Moody J, Davidson AV, Davidson DL. The effects of age on carbamazepine pharmacokinetics and adverse effects. Br J Clin Pharmacol. 1986;22(6):725-8.
54. Castleden CM, Allen JG, Altman J, St John-Smith P. A comparison of oral midazolam, nitrazepam and placebo in young and elderly subjects. Eur J Clin Pharmacol. 1987;32(3):253-7.
55. Roth T, Piccione P, Salis P, Kramer M, Kaffeman M. Effects of temazepam, flurazepam and quinalbarbitone on sleep: psychomotor and cognitive function. Br J Clin Pharmacol. 1979;8:47S-54S.
56. Mamelak M, Csima A, Buck L, Price V. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol. 1989;9(4):260-7.
57. Liem-Moolenaar M, Te Beek ET, De Kam ML, Franson KL, Kahn RS, Hijman R, et al. Central nervous system effects of haloperidol on THC in healthy male volunteers. J Psychopharmacol. 2010;24(11):1697-708.
58. Liem-Moolenaar M, Gray FA, De Visser SJ, Franson KL, Schoemaker RC, Schmitt JAJ, et al. Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol. J Psychopharmacol. 2010;24(1):73-82.
59. Liem-Moolenaar M, Rad M, Zamuner S, Cohen AF, Lemme F, Franson KL, et al. Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men. Br J Clin Pharmacol. 2011;71(6):907-16.
60. Wildin JD, Pleuvry BJ, Mawer GE. Impairment of psychomotor function at modest plasma concentrations of carbamazepine after administration of the liquid suspension to naive subjects. Br J Clin Pharmacol. 1993;35(1):14-9.
61. Cutson TM, Gray SL, Hughes MA, Carson SW, Hanlon JT. Effect of a single dose of diazepam on balance measures in older people. J Am Geriatr Soc. 1997;45(4):435-40.
62. Robin DW, Hasan SS, Lichtenstein MJ, Shiavi RG, Wood AJJ. Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther. 1991;49(5):581-8.
63. Kinirons MT, Lang CC, He HB, Ghebreselasie K, Shay S, Robin DW, et al. Triazolam pharmacokinetics and pharmacodynamics in Caucasians and southern Asians: ethnicity and CYP3A activity. Br J Clin Pharmacol. 1996;41:69-72.
64. Robin DW, Hasan SS, Edeki T, Lichtenstein MJ, Shiavi RG, Wood AJJ. Increased baseline sway contributes to increased losses of balance in older people following triazolam. J Am Geriatr Soc. 1996;44(3):300-4.
65. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol. 1993;13(2):100-6.
66. Whitmore JN, Fischer JR, Barton EC, Storm WF. Performance following a sudden awakening from daytime nap induced by zaleplon. Aviat Space Environ Med. 2004;75(1):29-36.
67. Linnoila M, Johnson J, Dubyoski K, Buchsbaum MS, Schneinin M, Kilts C. Effects of antidepressants on skilled performance. Br J Clin Pharmacol. 1984;18(Suppl. 1):109S-20S.
68. Strömberg C, Mattila MJ. Acute and subacute effects on psychomotor performance of femoxetine alone and with alcohol. Eur J Clin Pharmacol. 1985;28(6):641-7.
69. Mattila MJ, Vanakoski J, Mattila ME, Karonen S-L. Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects. Eur J Clin Pharmacol. 1994;46:215-20.
70. Mattila MJ, Vanakoski J, Kalska H, Seppälä T. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav. 1998;59(4):917-23.
71. Palva ES. Gender-related differences in diazepam effects on performance. Med Biol. 1985;63(2):92-5.
72. Mattila MJ, Aranko K, Mattila ME, Strömberg C. Objective and subjective assessment of hangover during subacute administration of temazepam and nitrazepam to healthy subjects. Eur J Clin Pharmacol. 1984;26(3):375-80.
73. Aranko K, Mattila MJ, Bordignon D. Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase. Acta Pharmacol et Toxicol. 1985;56(5):364-72.
74. Vanakoski J, Seppälä T, Strömberg C, Näveri L, Hammett J, Ford N. Effects of ceronapril alone or in combination with alcohol on psychomotor performance in healthy volunteers: a placebo-controlled, crossover study. Curr Ther Res. 2001;62(10):699-708.
75. Hege SG, Ellinwood EH, Wilson WH, Helligers CAM, Graham SM. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. Psychopharmacology. 1997;131:101-7.
76. McDevitt DG, Currie D, Nicholson AN, Wright NA, Zetlein MB. Central effects of the calcium antagonist, nifedipine. Br J Clin Pharmacol. 1991;32(5):541-9.
77. McDevitt DG, Currie D, Nicholson AN, Wright NA, Zetlein MB. Central effects of the diuretic, bendrofluazide. Br J Clin Pharmacol. 1994;38(3):249-56.
78. Nicholson AN, Wright NA, Zetlein MB, Currie D, McDevitt DG. Central effects of beta-adrenoceptor antagonists. II. Electroencephalogram and body sway. Br J Clin Pharmacol. 1988;26(2):129-41.
79. Nicholson AN, Wright NA, Zetlein MB, Currie D, McDevitt DG. Central effects of the angiotensin-converting enzyme inhibitor, captopril. II. Electroencephalogram and body sway. Br J Clin Pharmacol. 1990;30(4):537-46.
80. Kuitunen T, Mattila MJ, Seppälä T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam, and alcohol. Int Clin Psychopharmacol. 1990;5(Suppl. 2):115-30.
81. Kuitunen T, Matrila MJ, Seppälä T, Aranko K, Mattila ME. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br J Clin Pharmacol. 1990;30(3):453-61.
82. Jansen EC, Wachowiak-Andersen G, Münster-Swendsen J, Valentin N. Postural stability after oral premedication with diazepam. Anesthesiology. 1985;63(5):557-9.
83. Zammit G, Wang-Weigand S, Peng X. Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference. BMC Geriatr. 2008;8:15.
84. Delcker A, Wilhelm H, Timmann D, Diener HC. Side effects from increased doses of carbamazepine on neuropsychological and posturographic parameters of humans. Eur Neuropsychopharmacol. 1997;7(3):213-8.
85. Gupta SK, Ellinwood EH, Nikaido AM, Heatherly DG. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. J Pharmacokinet Biopharm. 1990;18(2):89-102.
86. Gupta SK, Ellinwood EH, Nikaido AM, Heatherly DG. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam. Pharm Res. 1990;7(6):570-6.
87. Mattila MJ, Patat A, Seppälä T, Kalska H, Jalava ML, Vanakoski J, et al. Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects. Eur J Clin Pharmacol. 1996;51(2):161-6.
88. Seppälä T, Nuotto E, Dreyfus JF. Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Pharmacology. 1983;27(Suppl. 2):127-35.
89. Mattila MJ, Mattila ME, Olkkola KT, Scheinin H. Effect of dexmedetomidine and midazolam on human performance and mood. Eur J Clin Pharmacol. 1991;41(3):217-23.
90. Rosenzweig P, Patat A, Zieleniuk I, Cimarosti I, Allain H, Gandon J-M. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor. Clin Pharmacol Ther. 1998;64(2):211-22.
91. Laghrissi-Thode F, Pollock BG, Miller MC, Mulsant BH, Altieri L, Finkel MS. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Psychopharmacol Bull. 1995;31(4):659-63.
92. Mamo DC, Pollock BG, Mulsant B, Houck PR, Bensasi S, Miller MC, et al. Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients. Am J Geriatr Psychiatry. 2002;10(2):199-205.
93. Laghrissi-Thode F, Pollock BG, Miller MC, Altieri L, Kupfer DJ. Comparative effects of sertraline and nortriptyline on body sway in older depressed patients. Am J Geriatr Psychiatry. 1995;3(3):217-28.
94. Perault M-C, Bergougnan L, Paillat A, Zieleniuk I, Rosenzweig P. Lack of interaction between amisulpride and lorazepam on psychomotor performance and memory in healthy volunteers. Hum Psychopharmacol. 1998;13(7):493-500.
95. Allain H, Tessier C, Bentué-Ferrer D, Tarral A, Le Breton S, Gandon J-M, et al. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology. 2003;165(4):419-29.
96. Patat A, Perault M-C, Vandel B, Danjou P, Brohier S, Zieleniuk I, et al. Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers. J Psychopharmacol. 1995;9(2):91-101.
97. Allain H, Bentué-Ferrer D, Tarral A, Gandon J-M. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects: a randomized, cross-over, double-blind study versus placebo. Eur J Clin Pharmacol. 2003;59(3):179-88.
98. Boyle J, Wolford D, Gargano C, McCrea JB, Cummings C, Cerchio K, et al. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects. Hum Psychopharmacol. 2009;24(1):61-71.
99. Allain H, Patat A, Lieury A, LeCoz F, Janus C, Menard G, et al. Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry. 1995;10(Suppl. 3):129s-35s.
100. Patat A, Perault M-C, Vandel B, Ulliac N, Zieleniuk I, Rosenzweig P. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers. Br J Clin Pharmacol. 1995;39(1):31-8.
101. Norris V, Baisley KJ, Calder N, Van Troostenburg A-R, Warrington SJ. Assessment of the AccuSwayPLUS system in measuring the effect of lorazepam on body sway in healthy volunteers. Int J Pharm Med. 2005;19(4):233-8.
102. Patat A, Alberini H, Bonhomme D, Soubrane C, Allain H, Gandon J-M. Effects of tiapride on electroencephalograms and cognitive functions in the elderly. Int Clin Psychopharmacol. 1999;14(4):199-208.
103. Patat A, Molinier P, Hergueta T, Brohier S, Zieleniuk I, Danjou P, et al. Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist. Int Clin Psychopharmacol. 1994;9(3):155-62.
104. Krupka E, Venisse N, Lafay C, Gendre D, Diquet B, Bouquet S, et al. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers. Eur J Clin Pharmacol. 2006;62(8):653-9.
105. Boyle J, Danjou P, Alexander R, Calder N, Gargano C, Agrawal NGB, et al. Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. Br J Clin Pharmacol. 2009;67(2):180-90.
106. Patat A, Klein MJ, Hucher M, Granier J. Acute effects of amitriptyline on human performance and interactions with diazepam. Eur J Clin Pharmacol. 1988;35(6):585-92.
107. Patat A, Foulhoux P. Effect on postural sway of various benzodiazepine tranquillizers. Br J Clin Pharmacol. 1985;20(1):9-16.
108. Ghoneim MM, Mewaldt SP, Hinrichs JV. Dose-response analysis of the behavioral effects of diazepam: II. Psychomotor performance, cognition and mood. Psychopharmacology. 1984;82(4):296-300.
109. Dorian P, Sellers EM, Reed KL, Warsh JJ, Hamilton C, Kaplan HL, et al. Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction. Eur J Clin Pharmacol. 1983;25(3):325-31.
110. Corbeil P, Rodrigue J, Simoneau M, Cohen H, Pourcher E. Influence of risperidone on balance control in young healthy individuals. Psychopharmacology. 2012;222(1):59-69.
111. Nakamura M, Ishii M, Niwa Y, Yamazaki M, Ito H. Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem. ORL J Oto-Rhino-Laryngol Relat Spec. 2005;67(2):106-12.
112. Draganich LF, Zacny J, Klafta J, Karrison T. The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people. J Gerontol Ser A Biol Sci Med Sci. 2001;56(1):M36-41.
113. Paleacu D, Shutzman A, Giladi N, Herman T, Simon ES, Hausdorff JM. Effects of pharmacological therapy on gait and cognitive function in depressed patients. Clin Neuropharmacol. 2007;30(2):63-71.
114. Hill SY, Goodwin DW, Reichman JB, Mendelson WB, Hopper S. A comparison of two benzodiazepine hypnotics administered with alcohol. J Clin Psychiatry. 1982;43(10):408-10.
115. Campbell AJ, Somerton DT. Benzodiazepine drug effect on body sway in elderly subjects. J Clin Exp Gerontol. 1982;4(4):341-7.
116. Tazaki T, Tada K, Nogami Y, Takemura N, Ishikawa K. Effects of butoctamide hydrogen succinate and nitrazepam on psychomotor function and EEG in healthy volunteers. Psychopharmacology. 1989;97(3):370-5.
117. Tada K, Sato Y, Sakai T, Ueda N, Kasamo K, Kojima T. Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. Neuropsychobiology. 1994;29(1):17-22.
118. Muraoka M, Tada K, Nogami Y, Ishikawa K, Nagoya T. Residual effects of repeated administration of triazolam and nitrazepam in healthy volunteers. Pharmacopsychiatry. 1992;25(3):134-9.
119. Noachtar S, Von Maydell B, Fuhry L, Büttner U. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers. Epilepsy Res. 1998;31(1):47-57.
120. Hindmarch I. Some aspects of the effects of clobazam on human psychomotor performance. Br J Clin Pharmacol. 1979;7:77S-82S.
121. Orr J, Dussault P, Chappel C, Goldberg L, Reggiani G. Relation between drug-induced central nervous system effects and plasma levels of diazepam in man. Mod Probl Pharmacopsychiatry. 1976;11:57-67.
122. Nikaido AM, Ellinwood EH, Heatherly DG, Dubow D. Differential CNS effects of diazepam in elderly adults. Pharmacol Biochem Behav. 1987;27(2):273-81.
123. Nikaido AM, Ellinwood EH. Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance. Psychopharmacology. 1987;92(4):459-64.
124. Nikaido AM, Ellinwood EH, Heatherly DG, Gupta SK. Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology. 1990;100(1):90-7.
125. McClelland GR, Cooper SM, Pilgrim AJ. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers. Br J Clin Pharmacol. 1990;30(6):795-803.
126. Beuzen JN, Taylor N, Wesnes K, Wood A. A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J Psychopharmacol. 1999;13(2):152-8.
127. Schuckit MA, Greenblatt D, Gold E, Irwin M. Reactions to ethanol and diazepam in healthy young men. J Stud Alcohol. 1991;52(2):180-7.
128. Seppälä T, Aranko K, Mattila MJ, Shrotriya RC. Effects of alcohol on buspirone and lorazepam actions. Clin Pharm Ther. 1982;32(2):201-7.
129. Van Vaerenbergh J, Broos P. Positive Romberg test and the probability of falls in the aged. Tijdschrift voor Gerontologie en Geriatrie. 1990;21(2):71-4.
130. Wright B. A simple mechanical ataxia-meter. J Physiol. 1971;218(Suppl.):27P-8P.
131. Piirtola M, Era P. Force platform measurements as predictors of falls among older people: a review. Gerontologia. 2006;52(1):1-16.
132. Caron O, Gelat T, Rougier P, Blanchi JP. A comparative analysis of the center of gravity and center of pressure trajectory path lengths in standing posture: an estimation of active stiffness. J Appl Biomech. 2000;16(3):234-47.
133. Thapa PB, Gideon P, Brockman KG, Fought RL, Ray WA. Clinical and biomechanical measures of balance as fall predictors in ambulatory nursing home residents. J Gerontol Ser A Biol Sci Med Sci. 1996;51(5):M239-46.
134. Hausdorff JM, Rios DA, Edelberg HK. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil. 2001;82(8):1050-6.
135. Maki BE. Gait changes in older adults: predictors of falls or indicators of fear. J Am Geriatr Soc. 1997;45(3):313-20.
136. Hausdorff JM, Edelberg HK, Cudkowicz ME, Singh MAF, Wei JY. The relationship between gait changes and falls. J Am Geriatr Soc. 1997;45(11):1406.
137. Plotnik M, Giladi N, Balash Y, Peretz C, Hausdorff JM. Is freezing of gait in Parkinson's disease related to asymmetric motor function? Ann Neurol. 2005;57(5):656-63.
138. Glassman AH, Bigger JT. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch Gen Psychiatry. 1981;38(7):815-20.
139. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des. 2004;10(20):2463-75.
140. Gill HS, DeVane CL, Risch SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol. 1997;17(5):377-89.
141. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351(9112):1303-7.
142. Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339(13):875-82.
143. Tinetti ME. Clinical practice: preventing falls in elderly persons. N Engl J Med. 2003;348(1):42-9.
144. Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med. 2002;18(2):141-58.
145. Hausdorff JM, Yogev G, Springer S, Simon ES, Giladi N. Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Exp Brain Res. 2005;164(4):541-8.
146. Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health. 2000;24(1):7-10.
147. Voyer P, Préville M, Cohen D, Berbiche D, Béland S-G. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging. 2010;29(2):205-13.
148. Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging. 2006;23(4):271-87.
149. Ray WA. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol. 1992;12(6):386-96.
150. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use. CNS Drugs. 2004;18(1):37-48.
151. Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3(5):485-93.
152. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18(5):297-328.
153. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in the elderly: pharmacoepidemiology and pharmacokinetics. Arch Fam Med. 1994;3(7):589-98.
154. Garrard J, Cloyd JC, Gross C, Hardie N, Thomas L, Lackner TE, et al. Factors associated with antiepileptic drug use among elderly nursing home residents. J Gerontol Ser A Biol Sci Med Sci. 2000;55A(7):M384-92.
155. Persson HBI, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia. 2002;43(7):768-72.
156. Mattson RH, Gidal BE. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav. 2004;5(Suppl. 2):S36-40.
157. Fife TD, Sirven J. Antiepileptic drugs and their impact on balance. Aging Health. 2005;1(1):147-55.
158. Nakken KO, Taubøll E. Bone loss associated with use of antiepileptic drugs. Expert Opin Drug Saf. 2010;9(4):561-71.
159. Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev. 2011;10:CD005185.
160. Morton DJ, Barrett-Connor EL, Edelstein SL. Thiazides and bone mineral density in elderly men and women. Am J Epidemiol. 1994;139(11):1107-15.
161. Van der Velde N, Stricker BHC, Pols HAP, Van der Cammen TJM. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging. 2007;24(8):691-9.
162. Tsunoda K, Uchida H, Suzuki T, Watanabe K, Yamashima T, Kashima H. Effects of discontinuing benzodiazepine-derivative hypnotics on postural sway and cognitive functions in the elderly. Int J Geriatr Psychiatry. 2010;25(12):1259-65.
163. Huang M-Y, Matsuura N, Kaneko Y, Ichinohe T. Midazolam increases bite force during intravenous sedation. J Oral Maxillofac Surg. 2012;70(8):e458-63.
164. Alexander NB. Postural control in older adults. J Am Geriatr Soc. 1994;42(1):93-108.
165. Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, Gagnon P, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59(3):383-9.
166. Louter M, Tromp SC. Parkinsonism due to the medication. Nederlands Tijdschrift voor Geneeskunde. 2009;153:A336.
167. Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60(11):2127-36.
168. Massion J. Postural control system. Curr Opin Neurobiol. 1994;4(6):877-87.
169. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol. 2004;19(3):437-54.
170. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19-34.